|
시장보고서
상품코드
2050535
생물학적 지표 시장 : 형태별, 유형별, 최종 사용자별, 유통 채널별, 지역별Biological Indicator Market, By Form, By Type, By End User, By Distribution Channel, By Geography |
||||||
생물학적 지표 시장은 2026년에 8억 9,590만 달러로 추계되고 있어 2033년까지 12억 8,600만 달러에 이를 것으로 예상되고 있습니다. 2026년부터 2033년까지 CAGR 5.3%로 성장할 전망입니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 8억 9,590만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 5.30% | 예측 금액(2033년) | 12억 8,600만 달러 |
세계 생물학적 지표 시장은 광범위한 의료 및 생명공학 산업에서 중요한 부문이며, 의료시설, 제약 제조, 의료기기 생산, 실험실 등 다양한 분야에서 멸균 공정에 필수적인 품질 보증 도구로 활용되고 있습니다. 생물학적 지표(포자 검사라고도 함)는 특정 미생물을 표준화한 시료로, 미생물의 사멸을 직접적으로 증명하여 멸균 과정의 효과를 나타냅니다. 이러한 지표에는 일반적으로 Geobacillus stearothermophilus 및 Bacillus atrophaeus와 같은 내성이 강한 박테리아의 포자가 포함되어 있으며, 이들은 대부분의 영양형 미생물이나 바이러스보다 본질적으로 멸균에 더 저항력이 있습니다.
이 시장에는 독립형 생물학적 지표, 생물학적 지표 스트립, 앰플, 바이알 등 다양한 제품 유형이 포함되어 있으며, 각각 증기, 에틸렌 옥사이드, 과산화수소, 방사선 멸균과 같은 특정 멸균 방법에 맞게 설계되어 있습니다. 규제 프레임워크가 점점 더 엄격해지고 의료 관련 감염이 전 세계적으로 심각한 문제로 떠오르면서 신뢰할 수 있는 생물학적 지표에 대한 수요가 크게 증가하고 있습니다. 제약 및 생명공학 분야의 확대, 환자 안전에 대한 관심 증가, 신흥국에서의 첨단 멸균 기술 채택 확대에 힘입어 시장 성장세가 더욱 가속화되고 있습니다.
시장 역학
세계 생물학적 지표 시장은 주로 미국 식품의약국(FDA), 미국 질병예방통제센터(CDC), 국제표준화기구 등이 부과하는 엄격한 규제 요건에 의해 주도되고 있습니다. 이들 기관은 의료 및 제약 환경에서 멸균 공정에 대한 정기적인 검증 및 모니터링을 의무화하고 있습니다. 의료 관련 감염(HAI) 증가 추세와 감염 예방에 대한 인식이 높아지면서 신뢰할 수 있는 멸균 모니터링 솔루션에 대한 수요가 크게 증가하고 있습니다. 또한, 특히 신흥 시장에서의 제약 및 생명공학 산업의 확대와 더불어 전 세계 수술 건수 증가는 시장 성장을 지속적으로 촉진하고 있습니다. COVID-19 팬데믹으로 인해 의료시설에서 감염 예방 프로토콜을 우선순위에 두게 되면서 도입이 더욱 가속화되고 있습니다.
그러나 고급 생물학적 지표 시스템에 따른 높은 비용, 개발도상국에서의 적절한 멸균 검증 절차에 대한 인식 부족, 일부 최종 사용자들이 더 비용 효율적이거나 더 편리하다고 생각하는 대체 화학적 및 물리적 모니터링 방법의 존재 등 시장 성장을 저해하는 요인이 있습니다. 모니터링 방법의 존재와 같은 특정 시장 성장 억제요인이 있습니다. 위양성 결과와 관련된 기술적 문제와 생물학적 지표의 결과를 해석하기 위한 전문적 훈련의 필요성도 시장을 억제하는 요인으로 작용하고 있습니다. 그럼에도 불구하고, 보다 빠른 결과를 제공하는 즉시 판독 가능한 생물학적 지표의 개발, 실시간 모니터링 및 데이터 관리를 위한 디지털 기술 및 IoT 기능의 통합, 그리고 의료 인프라 구축이 가속화되고 있는 신흥 시장으로의 진출에는 큰 기회가 존재합니다. 멸균 서비스 아웃소싱 증가와 일회용 의료기기의 채택 확대는 생물학적 지표 제조업체에게 더 많은 성장 기회를 제공합니다.
본 보고서의 주요 특징
- 이 보고서는 각 부문의 잠재적 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한, 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요한 고찰을 제공합니다.
- 세계 생물학적 지표 시장의 주요 기업 프로파일을 기업 개요, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등 다양한 파라미터를 기준으로 정리하여 수록하였습니다.
- 이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- '세계 생물학적 지표 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 생물학적 지표 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 생물학적 지표 시장 : 형태별(2021-2033년)
제5장 세계의 생물학적 지표 시장 : 유형별(2021-2033년)
제6장 세계의 생물학적 지표 시장 : 최종 사용자별(2021-2033년)
제7장 세계의 생물학적 지표 시장 : 유통 채널별(2021-2033년)
제8장 세계의 생물학적 지표 시장 : 지역별(2021-2033년)
제9장 경쟁 구도
제10장 애널리스트의 제안
제11장 참고 문헌 및 분석 방법
JHS 26.06.15Biological Indicator Market is estimated to be valued at USD 895.9 Mn in 2026 and is expected to reach USD 1,286.0 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.3% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 895.9 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.30% | 2033 Value Projection: | USD 1,286 Mn |
The global biological indicator market represents a critical segment within the broader healthcare and biotechnology industry, serving as an essential quality assurance tool for sterilization processes across various sectors including healthcare facilities, pharmaceutical manufacturing, medical device production, and research laboratories. Biological indicators, also known as spore tests, are standardized preparations of specific microorganisms that demonstrate the effectiveness of sterilization processes by providing direct evidence of microbial kill. These indicators typically contain highly resistant bacterial spores, such as Geobacillus stearothermophilus or Bacillus atrophaeus, which are naturally more resistant to sterilization than most vegetative microorganisms and viruses.
The market encompasses various product types including self-contained biological indicators, biological indicator strips, ampoules, and vials, each designed for specific sterilization methods such as steam, ethylene oxide, hydrogen peroxide, and radiation sterilization. As regulatory frameworks become increasingly stringent and healthcare-associated infections continue to pose significant challenges globally, the demand for reliable biological indicators has intensified substantially. The market's growth trajectory is further supported by the expanding pharmaceutical and biotechnology sectors, increasing emphasis on patient safety, and the growing adoption of advanced sterilization technologies in emerging economies.
Market Dynamics
The global biological indicator market is primarily driven by stringent regulatory requirements imposed by agencies such as the U.S. FDA, Centers for Disease Control and Prevention, and international standards organizations that mandate regular validation and monitoring of sterilization processes in healthcare and pharmaceutical environments. The increasing prevalence of healthcare-associated infections (HAIs) and the growing awareness about infection control measures have significantly boosted the demand for reliable sterilization monitoring solutions. Additionally, the expanding pharmaceutical and biotechnology industries, particularly in emerging markets, coupled with the rising number of surgical procedures worldwide, continue to fuel market growth. The COVID-19 pandemic has further accelerated adoption as healthcare facilities prioritize infection prevention protocols.
However, market growth faces certain constraints including the high costs associated with advanced biological indicator systems, limited awareness about proper sterilization validation procedures in developing regions, and the availability of alternative chemical and physical monitoring methods that may be perceived as more cost-effective or convenient by some end-users. Technical challenges related to false-positive results and the need for specialized training to interpret biological indicator results also present market restraints. Nevertheless, significant opportunities exist in the development of rapid-readout biological indicators that provide faster results, integration of digital technologies and IoT capabilities for real-time monitoring and data management, and expansion into emerging markets where healthcare infrastructure development is accelerating. The growing trend toward outsourcing sterilization services and the increasing adoption of single-use medical devices present additional growth avenues for biological indicator manufacturers.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global biological indicator market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include 3M Company, STERIS plc, Getinge AB, Cantel Medical Corp., Mesa Laboratories, Inc., Tuttnauer USA Co., Ltd., Matachana Group, Excelsior Scientific, Inc., Andersen Products, Inc., Propper Manufacturing Co., Inc., SSI Diagnostica A/S, Solventum, Medzell, Sigmaxis Innovations Pvt. Ltd., and Etigam BV
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global biological indicator market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global biological indicator market
Market Segmentation
- Form Insights (Revenue, USD Mn, 2021 - 2033)
- Self-Contained Biological Indicator
- Biological Indicator Strip
- Biological Indicator Disc
- Biological Indicator Vial
- Others (Biological Indicator Spore Suspension)
- Type Insights (Revenue, USD Mn, 2021 - 2033)
- Steam Sterilization
- Hydrogen Peroxide Sterilization
- Dry Heat Sterilization
- Others (Ethylene Oxide Sterilization)
- End User Insights (Revenue, USD Mn, 2021 - 2033)
- Biopharmaceutical Industry
- Medical Device Manufacturers
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Diagnostic Labs
- Others (Research Laboratories, etc.)
- Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Online
- Offline
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- 3M Company
- STERIS plc
- Getinge AB
- Mesa Laboratories, Inc.
- Tuttnauer USA Co., Ltd.
- Matachana Group
- Excelsior Scientific, Inc.
- Andersen Products, Inc.
- Propper Manufacturing Co., Inc.
- SSI Diagnostica A/S
- Solventum
- Medzell
- Sigmaxis Innovations Pvt. Ltd.
- Etigam BV
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Biological Indicator Market, By Form
- Global Biological Indicator Market, By Type
- Global Biological Indicator Market, By End User
- Global Biological Indicator Market, By Distribution Channel
- Global Biological Indicator Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Biological Indicator Market, By Form, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Self-Contained Biological Indicator
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Biological Indicator Strip
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Biological Indicator Disc
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Biological Indicator Vial
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others (Biological Indicator Spore Suspension)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
5. Global Biological Indicator Market, By Type, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Steam Sterilization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Hydrogen Peroxide Sterilization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Dry Heat Sterilization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others (Ethylene Oxide Sterilization)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
6. Global Biological Indicator Market, By End User, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Biopharmaceutical Industry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Medical Device Manufacturers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Diagnostic Labs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others (Research Laboratories, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
7. Global Biological Indicator Market, By Distribution Channel, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Online
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Offline
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
8. Global Biological Indicator Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Form, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- 3M Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- STERIS plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Getinge AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mesa Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tuttnauer USA Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Matachana Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Excelsior Scientific, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Andersen Products, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Propper Manufacturing Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- SSI Diagnostica A/S
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Solventum
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Medzell
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sigmaxis Innovations Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Etigam BV
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
